Sonic Healthcare (SHL) today reported a record interim net profit of A$137 million for the half year to 31 December 2008, an increase of 21% over the comparative period. The result was achieved on revenues of A$1,439 million, 28% higher than the corresponding period in the prior year.
Sonic’s CEO and Managing Director, Dr Colin Goldschmidt, said: “Sonic Healthcare has delivered another strong result for the half year and has shown the resilience of its business against global economic conditions and the current credit crisis. A particularly pleasing aspect of this result is the strong organic revenue growth of our laboratory operations. We have clearly taken market share in a number of our key markets, including Australia. The efforts of our management teams to identify and capture synergies are also bearing fruit, with strong margin expansion especially in Germany and the USA.”
Sonic’s Board has declared an interim dividend of 22 cents per share (franked to 60%), a 10% increase over the previous year’s interim dividend.
http://www.sonichealthcare.com/
